Plant ID: NPO29515
Plant Latin Name: Laurus nobilis
Taxonomy Genus: Laurus
Taxonomy Family: Lauraceae
NCBI TaxonomyDB:
85223
Plant-of-the-World-Online:
465049-1
Abortifacient; Antirheumatic; Antiseptic; Appetizer; Aromatic; Astringent; Cancer; Carminative; Diaphoretic; Digestive; Diuretic; Emetic; Emmenagogue; Narcotic; Parasiticide; Stimulant; Stomachic
Turkey; Afghanistan; Italy; India; France; Argentina; Israel; Algeria; China; Chile; Jordan; Iraq; Spain; Libya; United States; Morocco; Albania; Portugal; South Africa; Tunisia; Lebanon; Greece
TSHR; | |
CHRNA3; CHRNA4; | |
ALOX15; | |
PTGS1; | |
MCL1; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nicotinic acetylcholine receptor | CHRNA3 | Neuronal acetylcholine receptor subunit alpha-3 | P32297 | CHEMBL3068 |
Nicotinic acetylcholine receptor | CHRNA4 | Neuronal acetylcholine receptor protein alpha-4 subunit | P43681 | CHEMBL1882 |
Oxidoreductase | PTGS1 | Cyclooxygenase-1 | P23219 | CHEMBL221 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Unclassified | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | CHEMBL4361 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0007610; behavior | GO:0035095; behavioral response to nicotine | 3.149E-06 | 6.857E-02 | CHRNA3, CHRNA4 |
MF | GO:0060089; molecular transducer activity | GO:0015464; acetylcholine receptor activity | 2.289E-05 | 7.956E-02 | CHRNA3, CHRNA4 |
BP | GO:0050896; response to stimulus | GO:0095500; acetylcholine receptor signaling pathway | 3.781E-05 | 8.233E-02 | CHRNA3, CHRNA4 |
BP | GO:0023052; signaling | GO:0007271; synaptic transmission, cholinergic | 5.241E-05 | 9.511E-02 | CHRNA3, CHRNA4 |
BP | GO:0008152; metabolic process | GO:0006636; unsaturated fatty acid biosynthetic process | 6.060E-05 | 1.015E-01 | ALOX15, PTGS1 |
BP | GO:0008152; metabolic process | GO:0046456; icosanoid biosynthetic process | 9.924E-05 | 1.544E-01 | ALOX15, PTGS1 |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 2.125E-04 | 2.435E-01 | ALOX15, PTGS1 |
BP | GO:0065007; biological regulation | GO:0060078; regulation of postsynaptic membrane potential | 4.324E-04 | 2.853E-01 | CHRNA3, CHRNA4 |
CC | GO:0032991; macromolecular complex | GO:0097136; Bcl-2 family protein complex | 2.483E-03 | 5.198E-01 | MCL1 |
CC | GO:0044456; synapse part | GO:0045211; postsynaptic membrane | 3.184E-03 | 6.361E-01 | CHRNA3, CHRNA4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 5.654E-05 | 1.300E-03 | ALOX15, CYP3A4 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 1.398E-04 | 1.504E-03 | CHRNA3, CHRNA4, TSHR |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 2.133E-04 | 1.504E-03 | TSHR, PTGS1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 2.616E-04 | 1.504E-03 | ALOX15, PTGS1 |
09150 Organismal Systems | 09156 Nervous system | hsa04725 | Cholinergic synapse | 8.363E-04 | 3.263E-03 | CHRNA3, CHRNA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 8.513E-04 | 3.263E-03 | ALOX15, PTGS1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.049E-02 | 3.448E-02 | ALOX15, CYP3A4, PTGS1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 2.727E-02 | 4.145E-02 | CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 2.297E-02 | 4.145E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 2.883E-02 | 4.145E-02 | CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Drug abuse | F10-F19 | CHRNA3; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Cough | R05 | CHRNA3; |
G00-G99: Diseases of the nervous system G00-G99 | Spinal muscular atrophy | G00-G99 | SMN1;SMN2; |